Eruption of Metastatic Paraganglioma After Successful Therapy with 177Lu/90Y-DOTATOC and 177Lu-DOTATATE

Authors:

Abstract
Metastatic paraganglioma treatment options are limited. Peptide receptor radionuclide therapy (PRRT) has been introduced as a novel management option for m
Funding Information
  • National Institute of Child Health and Human Development (Z1AHD008735)

This publication has 34 references indexed in Scilit: